Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use

Human Gene Therapy

Volumn 10, Issue 15, 1999, Pages 2445-2450

  Grimm, Dirk ^a   Kleinschmidt, Jürgen A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; CELL TYPE; CONTAMINATION; CRYSTALLIZATION; GENE TARGETING; GENETIC TRANSFECTION; HELPER CELL; IMMUNOCOMPETENCE; NONHUMAN; REVIEW; TARGET CELL; VIRUS INFECTION;

ANIMALS; DEPENDOVIRUS; HELPER VIRUSES; HUMANS; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; DNA VIRUSES; PARVOVIRUS;

EID: 0033544010     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016799     Document Type: Review

References (32)

1. ALLEN, J.M., DEBELAK, D.J., REYNOLDS, T.C., and MILLER, A.D. (1997). Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J. Virol. 9, 6816-6822.
2. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 12, 1531-1541.
3. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 10, 1329-1341.
4. CLARK, K.R., LIU, X., McGRATH, J.P., and JOHNSON, P.R. (1999). Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10, 1031-1039.
5. CONWAY, J.E., ZOLOTUKHIN, S., MUZYCZKA, N., HAYWARD, G.S., and BYRNE, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 11, 8780-8789.
6. CONWAY, J.E., AP RHYS, C.M.J., ZOLOTUKHIN, I., ZOLOTUKHIN, S., MUZYCZKA, N., HAYWARD, G.S., and BYRNE, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther. 6, 986-993.
7. FAN, P.D., and DONG, J.Y. (1997). Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Hum. Gene Ther. 1, 87-98.
8. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 5, 3227-3234.
9. GAO, G.P., QU, G., FAUST, L.Z., ENGDAHL, R.K., XIAO, W., HUGHES, J.V., ZOLTICK, P.W., and WILSON, J.M. (1998). High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9, 2353-2362.
10. GRIMM, D., KERN, A., RITTNER, K., and KLEINSCHMIDT, J.A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9, 2745-2760.
11. HERZOG, R.W., HAGSTROM, J.N., KUNG, S.H., TAI, S.J., WILSON, J.M., FISHER, K.J., and HIGH, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 11, 5804-5809.
12. INOUE, N., and RUSSELL, D.W. (1998). Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J. Virol. 72, 7024-7031.
13. JOHNSTON, K.M., JACOBY, D., PECHAN, P.A., FRAEFEL, C., BORGHESANI, P., SCHUBACK, D., DUNN, R.J., SMITH, F.I., and BREAKEFIELD, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 3, 359-370.
14. JORDAN, M., KÖHNE, C., and WURM, F.M. (1998). Calcium-phosphate mediated DNA transfer into HEK-293 cells in suspension: Control of physicochemical parameters allows transfection in stirred media. Cytotechnology 26, 39-47.
15. LI, J., SAMULSKI, R.J., and XIAO, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 7, 5236-5243.
16. LIU, X.L., CLARK, K.R., and JOHNSON, P.R. (1999). Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther. 6, 293-299.
17. MATSUSHITA, T., ELLIGER, S., ELLIGER, C., PODSAKOFF, G., VILLARREAL, L., KURTZMAN, G.J., IWAKI, Y., and COLOSI, P. (1998). Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther. 5, 938-945.
18. McLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988). Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973.
19. MONAHAN, P.E., SAMULSKI, R.J., TAZELAAR, J., XIAO, X., NICHOLS, T.C., BELLINGER, D.A., READ, M.S., and WALSH, C.E. (1998). Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5, 40-49.
20. PALOMBO, F., MONCIOTTI, A., RECCHIA, A., CORTESE, R., CILIBERTO, G., and LAMONICA, M.N. (1998). Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72, 5025-5034.
21. RECCHIA, A., PARKS, R.J., LAMARTINA, S., TONIATTI, C., PIERONI, L., PALOMBO, F., CILIBERTO, G., GRAHAM, F.L., CORTESE, R., LAMONICA, N., and COLLOCA, S. (1999). Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 96, 2615-2620.
22. SALVETTI, A., ORÈVE, S., CHADEUF, G., FAVRE, D., CHEREL, Y., CHAMPION-ARNAUD, P., DAVID-AMELINE, J., and MOULLIER, P. (1998). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
23. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 9, 3822-3828.
24. SNYDER, R.O., XIAO, X., and SAMULSKI, R.J. (1996). Production of recombinant adeno-associated viral vectors. In Current Protocols in Human Genetics. N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Morton, C. Seidman, J. Seidman, and D. Smith, eds. (John Wiley & Sons, New York) pp. 12.1.1-24.
25. SNYDER, R.O., MIAO, C.H., PATIJN, G.A., SPRATT, S.K., DANOS, O., NAGY, D., GOWN, A.M., WINTHER, B., MEUSE, L., COHEN, L.K., THOMPSON, A.R., and KAY, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276.
26. TAMAYOSE, K., HIRAI, Y., and SHIMADA, T. (1996). A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 4, 507-513.
27. VINCENT, K.A., PIRAINO, S.T., and WADSWORTH, S.C. (1997). Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J. Virol. 3, 1897-1905.
28. WANG, X.S., KHUNTIRAT, B., QING, K., PONNAZHAGAN, S., KUBE, D.M., ZHOU, S., DWARKI, V.J., and SRIVASTAVA, A. (1998). Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J. Virol. 72, 5472-5480.
29. WEGER, S., WISTUBA, A., GRIMM, D., and KLEINSCHMIDT, J.A. (1997). Control of adeno-associated virus type 2 cap gene expression: Relative influence of helper virus, terminal repeats, and Rep proteins. J. Virol. 11, 8437-8447.
30. WISTUBA, A., KERN, A., WEGER, S., GRIMM, D., and KLEINSCHMIDT, J.A. (1997). Subcellular compartmentalization of adenoassociated virus type 2 assembly. J. Virol. 2, 1341-1352.
31. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 3, 2224-2232.
32. ZOLOTUKHIN, S., BYRNE, B.J., MASON, E., ZOLOTUKHIN, I., POTTER, M., CHESNUT, K., SUMMERFORD, C., SAMULSKI, R.J., and MUZYCZKA, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.